Top Life Sciences Companies To Watch In Right Now

With shares of Corning (NYSE:GLW) trading around $17, is GLW an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework.

T = Trends for a Stock’s Movement

Corning produces and sells specialty glasses, ceramics, and related materials worldwide. It operates in five segments: Display Technologies, Telecommunications, Environmental Technologies, Specialty Materials, and Life Sciences. Corning has launched Corning Lotus Glass, an environmentally friendly display glass for organic LED and LCD displays that are used in portable devices such as smartphones, tablets, and notebook computers. Smart phones, tablets, notebook computers, and their related materials are seeing explosive growth in developed and developing countries around the world.

Corning on Tuesday announced its results for the fourth quarter and full year of 2013.�Core earnings per share were 29 cents, an increase of 4 percent over last year�� fourth quarter and better than expected. GAAP earnings per share were 30 cents.�Core sales were $2 billion, a 2 percent decline from the comparable period last year.��013 was a very successful year for Corning,��Wendell P. Weeks, chairman, chief executive officer, and president, said in the earnings report. ��e achieved the company�� primary performance goal of restoring earnings growth. This was accomplished by regaining positive momentum in our LCD business and growing the earnings in our other segments. We also delivered on our commitment to enhance shareholder value by increasing the cash dividend and executing more than $1.5 billion in share repurchases. The company�� performance was recognized by a 41% improvement in the year�� share price, a result with which we are delighted.��/p>

Top Integrated Utility Companies To Buy Right Now: UnipolSai Assicurazioni SpA (US)

UnipolSai Assicurazioni SpA, formerly Fondiaria SPA, is an Italy- based company engaged in financial sector. The Company is a result of the merger of Unipol Assicurazioni SpA, Milano Assicurazioni SpA and Premafin Finanziaria SpA into Fondiaria Sai SpA. The Company operates through approximately 3 000 agencies under brands, such as Unipol, Sai, La Fondaria, Milano, La Previdente, Nuova Maa and Sasa. UnipolSai Assicurazioni SpA specializes in non-life insurance, especially automobile insurance. Additionally, UnipolSai Assicurazioni SpA provides products which protect its clients against damage and accident in the field, such as work, home, travel, health, life, aviation, railway, fire, maritime and goods in transit, as well as reinsurance and legal protection. Advisors' Opinion:

• [By John Heinzl]

  Consider Netflix (NFLX), the video-streaming company whose stock has risen more than five-fold in the past year, and which closed Friday at $328.03 (US). The most pessimistic analyst on Wall Street has a 12-month target of $72; the most optimistic has a target of $460. Such wide dispersion indicates that analysts don't really know how to value the company; there are too many variables at play.

• [By Vivian Lewis, Editor and Publisher, Global Investing]

  It just bought 334 factories for $372 million (US) in conjunction with AIG (of the US) and Walton St. Capital, a Mexican developer, in northern Mexico, which are 97% occupied.

• [By Chris Umiastowki]

  Over the next three days, the company sold over nine million of the new iPhone models, breaking last year's record of five million when the iPhone 5 was launched. This tremendous unit growth is in stark contrast to the company's stock price, which has dropped from about $650 (US) last year, to below $500 now. And it's a major reason I'm still enthusiastic about the stock.

Top Life Sciences Companies To Watch In Right Now: Qlik Technologies Inc.(QLIK)

Qlik Technologies Inc. engages in the development, commercialization, and implementation of software products and related services for user-driven business intelligence that enables customers to make business decisions primarily in the Americas, Europe, the Asia-Pacific region, and Africa. It provides QlikView Business Discovery platform, which helps people create and share insights and analysis in groups and across organizations. Business users can explore data, ask and answer their own stream of questions, and follow their own path to insight on their own and in teams and groups. The company also offers maintenance and professional services. It sells its products to a range of industry verticals, including consumer packaged goods, financial services, pharmaceuticals, retail, manufacturing, technology, and healthcare through its direct sales force, as well as through an indirect channel partners comprising distribution partners, value-added resellers, system integrators, and original equipment manufacturers to license and support its software platform. The company was founded in 1993 and is headquartered in Radnor, Pennsylvania.

Advisors' Opinion:

• [By Garrett Cook]

  Shares of Qlik Technologies (NASDAQ: QLIK) got a boost, shooting up 12.48 percent to $26.31 after the company reported better-than-expected quarterly results.

• [By Tim Beyers and Erin Miller]

  Shares of Qlik Technologies (NASDAQ: QLIK  ) are on the move. The company, which made a name for itself delivering business intelligence and analytics to anyone, anywhere via mobile devices, popped 13% after reporting strong revenue gains and upbeat guidance.

• [By Lauren Pollock]

  Qlik Technologies Inc.'s(QLIK) third-quarter earnings soared due to a tax benefit, but higher costs more than offset revenue growth. Shares dropped as revenue missed expectations and the company’s outlook for the current quarter was short of analysts’ estimates.

• [By Eric Volkman]

  Qlik Technologies (NASDAQ: QLIK  ) will have a new CFO once July rolls around. The company said that Tim MacCarrick is to take up the post on July 1. He replaces Bill Sorenson, who announced his departure from the firm in February. The two men will temporarily work together to "ensure a smooth transition," according to a company press release announcing the news.

Top Life Sciences Companies To Watch In Right Now: Ryanair Holdings PLC (RYA)

Ryanair Holdings plc (Ryanair Holdings), is a holding company for Ryanair Limited (Ryanair). Ryanair operates a low-cost, scheduled-passenger airline serving short-haul, point-to-point routes between Ireland, the United Kingdom, Continental Europe, and Morocco. As of June 30, 2012, the Company offered approximately over 1,500 scheduled short-haul flights per day serving approximately 160 airports largely throughout Europe with an operating fleet of 294 aircraft flying approximately 1,500 routes. Ryanair sells seats on a one-way basis. The Company also holds a 29.8% interest in Aer Lingus Group plc. As of June 30, 2012, Ryanair�� operating fleet was composed of 294 Boeing 737-800 aircraft, each having 189 seats. Ryanair�� fleet totaled 294 Boeing 737-800s at March 31, 2012. As of June 30, 2012, Ryanair owned and operated four Boeing 737-800 full flight simulators for pilot training. Advisors' Opinion:

• [By Inyoung Hwang]

  Ryanair Holdings Plc (RYA), the discount airline operator that�� the second-biggest stock in Ireland�� ISEQ index, declined 1.7 percent to 7.23 euros in Dublin. Kerry Group, a supplier of food ingredients, sank 1.4 percent to 45.24 euros.

Top Life Sciences Companies To Watch In Right Now: pSivida Corp.(PSDV)

pSivida Corp., together with its subsidiaries, develops drug delivery products for treatment of back-of-the-eye diseases that are administered by implantation, injection, or insertion. The company?s lead product candidate includes Iluvien, which is in Phase III clinical trials and delivers fluocinolone acetonide (FA) for the treatment of diabetic macular edema (DME), a cause of vision loss. It is also conducting Phase II clinical trials with Iluvien for the treatment of wet and dry form of age-related macular degeneration, and retinal vein occlusion. In addition, the company?s products include Retisert for the treatment of posterior uveitis, an autoimmune condition characterized by inflammation of the posterior of the eye that can cause sudden or gradual vision loss; and Vitrasert for cytomegalovirus retinitis, a blinding eye disease that occurs in individuals with advanced AIDS. It is developing the Latanoprost product, an injectable, bioerodible drug delivery implant i n Phase I/II dose-escalating study for the treatment of glaucoma and ocular hypertension; the Posterior Uveitis product candidate in a Phase I/II study for the treatment of posterior uveitis; BioSilicon technology system, which is nano-structured porous silicon designed for use as a drug delivery platform and to deliver smaller molecules; and Tethadur, which utilizes BioSilicon to deliver large biologic molecules, including peptides and proteins. It has strategic collaborations with Bausch & Lomb Incorporated; Alimera Sciences, Inc.; Pfizer, Inc.; and Intrinsiq Materials Cayman Limited. The company was founded in 1987 and is headquartered in Watertown, Massachusetts.

Advisors' Opinion:

• [By John Kell]

  Specialty pharmaceutical firm pSivida Corp.(PSDV) said the U.S. Food and Drug Administration didn’t approve a treatment for an eye disease found in patients with diabetes. The company’s stock tumbled 47% to $2 premarket, while shares of Alimera Sciences Inc.(ALIM) were down 39% to $1.66, as the treatment is licensed and sold by Alimera in other markets.

• [By Smith On Stocks]

  This note focuses on the implications of the complete response letter (CRL) received by Alimera (ALIM) for Iluvien. This product was developed by pSivida (PSDV) but was partnered with Alimera. This report deals only with the investment significance for pSivida.

Top Life Sciences Companies To Watch In Right Now: Books-A-Million Inc.(BAMM)

Books-A-Million, Inc. operates as a book retailer in the southeastern United States. The company operates superstores and traditional bookstores that offer a selection of hardcover and paperback books, magazines, and newspapers. It also offers other merchandise, including gifts, cards, collectibles, magazines, music, DVDs, and electronic accessories, as well as coffee, tea, and other edible products. The company markets its products under the trademarks of Books-A-Million, BAM! Books-A-Million, Bookland, Books & Co., Millionaire?s Club, Sweet Water Press, Thanks-A-Million, Big Fat Coloring Book, Up All Night Reader, Read & Save Rebate, Readables Accessories for Readers, Kids-A-Million, Teachers First, The Write-Price, Bambeanos, Hold That Thought, Book$mart, BAMM, BAMM.com, BOOKSAMILLION.com, Chillatte, Joe Muggs Newsstand, Page Pets, JOEMUGGS.com, FAITHPOINT.com, Faithmark, Joe Muggs, Anderson?s Bookland, Snow Joe, Summer Says, On the John University, OTJU, American Whole sale Book Company, AWBC, and NetCentral. It also offers its products over the Internet at Booksamillion.com. As of August 11, 2011, the company operated 231 stores in 23 states and the District of Columbia. Books-A-Million, Inc. was founded in 1917 and is based in Birmingham, Alabama.

Advisors' Opinion:

• [By John Udovich]

  Vitamin Shoppe Inc (NYSE: VSI), Books-A-Million, Inc (NASDAQ: BAMM) and Perfumania Holdings, Inc (NASDAQ: PERF) have the dubious distinction of being�the worst performing small cap�specialty retail stocks for this year (according to Finviz.com) with losses of 4.85% and�3% and a gain of 0.61%, respectively, since the start of the year (See my previous article: This Year�� Best Performing Small Cap Specialty Retail Stocks? UNTD, TA & HZO). I should mention that the definition of specialty retail stocks might vary from one stock screener to another, but what�� clear is that these three small cap retail stocks have been heading in the wrong direction for investors for much of this year. �With that in mind, what sort of performance should investors expect from these small cap specialty retail stocks on Black Friday and for the all important holiday season? Here is what you need to be aware of:

Top Life Sciences Companies To Watch In Right Now: Spectral Diagnostics Inc (DIAGF)

Spectral Diagnostics Inc. (Spectral), incorporated on July 29, 1991, focuses on the development and commercialization, in North America, treatment for severe sepsis and septic shock. The Company also manufactures and sells certain reagents. Its products include Rapid Diagnostics for Sepsis, Endotoxin Activity Assay (EAA) and Toraymyxin. As of December 31, 2011, Spectral�� EAA endotoxin measurement was the only the United Sates Food and Drug Administration (FDA) cleared diagnostic on the market. Spectral Diagnostics (US) Inc. and Spectral Diagnostics (New Brunswick) Inc. are its subsidiaries.

The Company has developed a rapid diagnostic test for detection of components of gram negative bacterial cell wall (endotoxin). The EAA instrument is manufactured under contract for use in the hospital setting. The Toraymyxin hemoperfusion device removes endotoxin from the bloodstream and is manufactured by Toray Industries Inc. of Japan. The product is sold in Japan and Europe and has been used over 80,000 patients worldwide. As of December 31, 2011, Spectral was conducting clinical trials for the purpose of seeking regulatory approval in the United States. Spectral develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies. Royalty revenues are earned from these license arrangements based on a percentage of end user sales of Troponin I.

The Company competes with Eli Lilly, Agennix AG, AstraZeneca, Eisai, Gambro, InflammaGen Therapeutics, Fresenius and CytoSorbents.

Advisors' Opinion:

• [By maarnio]

  Spectral Diagnostics (DIAGF) develops and commercializes theranostic treatment for severe sepsis in North America.

  Shares outstanding (March 31, 2014)

Top Life Sciences Companies To Watch In Right Now: Northern Oil and Gas Inc.(NOG)

Northern Oil and Gas, Inc., an independent energy company, engages in the acquisition, exploration, exploitation, development, and production of crude oil and natural gas properties in the Williston Basin Bakken play, the United States. As of June 30, 2011, the company?s principal assets included approximately 158,046 net acres located in the northern region of the United States; and 439 gross wells. Northern Oil and Gas, Inc. is based in Wayzata, Minnesota.

Advisors' Opinion:

• [By Bret Jensen]

  Northern Oil & Gas (NOG) is another slightly bigger (~$1B market capitalization) Bakken player that should benefit from the same well completion techniques that Whiting is currently pioneering. The company is growing revenues in the mid-teens and analysts expect this to continue in FY2014 and beyond.

• [By Matt DiLallo]

  4. Northern Oil & Gas (NYSEMKT: NOG  )
  Bakken-focused Northern Oil & Gas delivered oil production growth of 93.4% last year. The company spent about $485 million to drill a total of 48.3 net wells, which delivered that production growth. What's unique about Northern is that it typically just takes a small, non-operated stake in each well, as the company actually participated in the drilling of 563 gross wells last year. That spreads its risk, as one dry hole won't have much of an impact on its returns. The company plans to continue to grow its oil production this year, as it's currently working with its partners to drill 152 gross (12.2 net) wells to keep oil production growing.

• [By Sean Williams]

  Northern (under)exposure
  No one ever said being an oil and gas driller was easy. Costs to build out a company, drill, and hire a workforce are huge, and if spot oil, liquid natural gas, and natural gas prices don't cooperate relatively quickly, then the chances of success can be quite low. However, I think the market isn't giving nearly enough credit to small-time Bakken shale player Northern Oil & Gas (NYSEMKT: NOG  ) , which has all the tools essential for long-term profits.